Corporation Yuhan Corporation to Receive $15 Million in Technology Fees for Lekraza in JapanMay 31, 2025 Yuhan Corporation will receive $15 million in technology fees following the launch of its new lung cancer drug ‘Lekraza’ in Japan.
